Literature DB >> 34994206

Unique Associations of DNA Methylation Regions With 24-Hour Blood Pressure Phenotypes in Black Participants.

Michelle L Roberts1, Theodore A Kotchen2, Xiaoqing Pan1,3, Yingchuan Li1,4, Chun Yang1, Pengyuan Liu1,5, Tao Wang, Purushottam W Laud6, Thomas H Chelius7, Yannick Munyura2, David L Mattson8, Yong Liu, Allen W Cowley1, Srividya Kidambi2, Mingyu Liang1.   

Abstract

BACKGROUND: Epigenetic marks (eg, DNA methylation) may capture the effect of gene-environment interactions. DNA methylation is involved in blood pressure (BP) regulation and hypertension development; however, no studies have evaluated its relationship with 24-hour BP phenotypes (daytime, nighttime, and 24-hour average BPs).
METHODS: We examined the association of whole blood DNA methylation with 24-hour BP phenotypes and clinic BPs in a discovery cohort of 281 Blacks participants using reduced representation bisulfite sequencing. We developed a deep and region-specific methylation sequencing method, Bisulfite ULtrapLEx Targeted Sequencing and utilized it to validate our findings in a separate validation cohort (n=117).
RESULTS: Analysis of 38 215 DNA methylation regions (MRs), derived from 1 549 368 CpG sites across the genome, identified up to 72 regions that were significantly associated with 24-hour BP phenotypes. No MR was significantly associated with clinic BP. Two to 3 MRs were significantly associated with various 24-hour BP phenotypes after adjustment for age, sex, and body mass index. Together, these MRs explained up to 16.5% of the variance of 24-hour average BP, while age, sex, and BMI explained up to 11.0% of the variance. Analysis of one of the MRs in an independent cohort using Bisulfite ULtrapLEx Targeted Sequencing confirmed its association with 24-hour average BP phenotype.
CONCLUSIONS: We identified several MRs that explain a substantial portion of variances in 24-hour BP phenotypes, which might be excellent markers of cumulative effect of factors influencing 24-hour BP levels. The Bisulfite ULtrapLEx Targeted Sequencing workflow has potential to be suitable for clinical testing and population screenings on a large scale.

Entities:  

Keywords:  DNA methylation; blood pressure; epigenetics; hypertension

Mesh:

Year:  2022        PMID: 34994206      PMCID: PMC8917053          DOI: 10.1161/HYPERTENSIONAHA.121.18584

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  49 in total

1.  Role of DNA Methylation in Modulating Transcription Factor Occupancy.

Authors:  Matthew T Maurano; Hao Wang; Sam John; Anthony Shafer; Theresa Canfield; Kristen Lee; John A Stamatoyannopoulos
Journal:  Cell Rep       Date:  2015-08-06       Impact factor: 9.423

Review 2.  Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension.

Authors:  Allen W Cowley; Joseph H Nadeau; Andrea Baccarelli; Kathleen Berecek; Myriam Fornage; Gary H Gibbons; David G Harrison; Mingyu Liang; Peter W Nathanielsz; Daniel T O'Connor; Jose Ordovas; Weiqun Peng; Marcelo Bento Soares; Moshe Szyf; H Eser Tolunay; Katherine C Wood; Keji Zhao; Zorina S Galis
Journal:  Hypertension       Date:  2012-03-19       Impact factor: 10.190

3.  Locus-Specific DNA Methylation Analysis by Targeted Deep Bisulfite Sequencing.

Authors:  Elsa Leitão; Jasmin Beygo; Michael Zeschnigk; Ludger Klein-Hitpass; Marcel Bargull; Sven Rahmann; Bernhard Horsthemke
Journal:  Methods Mol Biol       Date:  2018

4.  Stability of global methylation profiles of whole blood and extracted DNA under different storage durations and conditions.

Authors:  Yingchuan Li; Xiaoqing Pan; Michelle L Roberts; Pengyuan Liu; Theodore A Kotchen; Allen W Cowley; David L Mattson; Yong Liu; Mingyu Liang; Srividya Kidambi
Journal:  Epigenomics       Date:  2018-04-23       Impact factor: 4.778

5.  Enhanced 24-hour norepinephrine and renin secretion in young patients with essential hypertension: relation with the circadian pattern of arterial blood pressure.

Authors:  M L Tuck; N Stern; J R Sowers
Journal:  Am J Cardiol       Date:  1985-01-01       Impact factor: 2.778

Review 6.  Redox Stress Defines the Small Artery Vasculopathy of Hypertension: How Do We Bridge the Bench-to-Bedside Gap?

Authors:  Rhian M Touyz; Augusto C Montezano; Francisco Rios; Michael E Widlansky; Mingyu Liang
Journal:  Circ Res       Date:  2017-05-26       Impact factor: 17.367

7.  Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications.

Authors:  Felix Krueger; Simon R Andrews
Journal:  Bioinformatics       Date:  2011-04-14       Impact factor: 6.937

8.  Hypertension, insulin resistance, and aldosterone: sex-specific relationships.

Authors:  Srividya Kidambi; Jane M Kotchen; Shanthi Krishnaswami; Clarence E Grim; Theodore A Kotchen
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-03       Impact factor: 3.738

9.  An integrated encyclopedia of DNA elements in the human genome.

Authors: 
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

10.  Agreement in DNA methylation levels from the Illumina 450K array across batches, tissues, and time.

Authors:  Marie Forest; Kieran J O'Donnell; Greg Voisin; Helene Gaudreau; Julia L MacIsaac; Lisa M McEwen; Patricia P Silveira; Meir Steiner; Michael S Kobor; Michael J Meaney; Celia M T Greenwood
Journal:  Epigenetics       Date:  2018-01-30       Impact factor: 4.528

View more
  2 in total

Review 1.  Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials.

Authors:  Yuncong Shi; Huanji Zhang; Suli Huang; Li Yin; Feng Wang; Pei Luo; Hui Huang
Journal:  Signal Transduct Target Ther       Date:  2022-06-25

2.  Maternal blood pressure associates with placental DNA methylation both directly and through alterations in cell-type composition.

Authors:  Lucile Broséus; Daniel Vaiman; Jörg Tost; Camino Ruano San Martin; Milan Jacobi; Joel D Schwartz; Rémi Béranger; Rémy Slama; Barbara Heude; Johanna Lepeule
Journal:  BMC Med       Date:  2022-10-20       Impact factor: 11.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.